Approaches for Initial Prostate Biopsy and Antibiotic Prophylaxis

Area of Science:

• Urology
• Oncology
• Diagnostic Imaging

Background:

• The optimal technique for initial prostate biopsy (PB) is a subject of ongoing debate and evolving recommendations.
• Current decision-making for PB relies on digital rectal examination and prostate-specific antigen (PSA) levels, lacking a definitive cutoff.
• Antimicrobial resistance necessitates careful consideration of antibiotic prophylaxis strategies for PB.

Purpose of the Study:

• To review recent advancements in initial prostate biopsy (PB) techniques.
• To summarize current recommendations for PB and associated antibiotic prophylaxis.
• To explore emerging strategies for prostate cancer diagnosis.

Main Methods:

• A nonsystematic literature review was conducted using PubMed and Embase databases up to October 2014.
• Articles were selected based on the highest level of evidence, prioritizing publications from the past five years.
• Focus was placed on recent advances and current recommendations for initial PB and antibiotic prophylaxis.

Main Results:

• The 12-core transrectal (TR) ultrasound-guided biopsy remains the standard of care for initial PB.
• Biomarkers are being investigated to refine PSA-based decision-making and reduce overdiagnosis.
• Imaging-guided targeted PB strategies, potentially combined with random biopsies, show promise for the future of prostate cancer diagnosis.

Conclusions:

• The 12-core TR biopsy scheme is the established standard for initial prostate cancer detection.
• Emerging trends favor new biomarkers and imaging-guided targeted strategies to avoid overdiagnosis of low-risk cancers.
• The cost-benefit analysis of novel PB techniques is crucial for their integration into clinical practice.